MARKET PULSE-Solar stocks, Saks, Intersil, Synta Pharma, Spherix

Mon Jul 29, 2013 10:41am EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article | Single Page
[-] Text [+]

(For more market insights, including options activity, click on ; for the Day Ahead newsletter; for the Morning News Call newsletter,

July 29 (Reuters) - Some U.S. stocks on the move on Monday:


U.S. stocks dipped on Monday as a week packed with data and central bank meetings got under way, with the S&P 500 within a few points of its record close set a week ago. The Dow Jones industrial average .DJI fell 39.54 points or 0.25 percent, to 15,519.29, the S&P 500 .SPX lost 4.67 points or 0.28 percent, to 1,686.98 and the Nasdaq Composite .IXIC dropped 3.58 points or 0.1 percent, to 3,609.59.

** SYNTA PHARMACEUTICALS CORP, $5.87, up 16 pct (0946 ET)

The biopharmaceutical company said a proof-of-concept study on its drug candidate ganetespib as a treatment for breast cancer has met its goal. Preliminary data showed the study could now be expanded and taken to its next stage, the company said.

Roth Capital Partners, which raised its price target on the stock to $20 from $18, said Synta remained attractive based primarily on the promise of ganetespib in several oncology indications.   Continued...